STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Elutia (Nasdaq: ELUT), a drug-eluting biomatrix technologies company, has scheduled its second quarter 2025 financial results release for Thursday, August 14, 2025, after market close.

The company will host a conference call and webcast at 5:00 p.m. Eastern Time on the same day. Management will be available to discuss the results, with both domestic and international dial-in numbers provided for investor participation.

[]
Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.49% News Effect

On the day this news was published, ELUT gained 0.49%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

GAITHERSBURG, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its second quarter 2025 financial results after market close on Thursday, August 14, 2025. Members of the Company’s management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13754773

Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.

About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com

This press release was published by a CLEAR® Verified individual.


FAQ

When will Elutia (ELUT) release its Q2 2025 earnings?

Elutia will release its Q2 2025 financial results after market close on Thursday, August 14, 2025.

What time is Elutia's Q2 2025 earnings conference call?

Elutia's earnings conference call is scheduled for 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on August 14, 2025.

How can investors access Elutia's Q2 2025 earnings call?

Investors can access the call via webcast on Elutia's investor website, or by phone using 877-407-8029 (US) or 201-689-8029 (International) with Conference ID: 13754773.

Where can I find the webcast of Elutia's Q2 2025 earnings call?

The live and archived webcast will be available on the 'Investors' section of Elutia's website at investors.elutia.com.
Elutia Inc.

NASDAQ:ELUT

ELUT Rankings

ELUT Latest News

ELUT Latest SEC Filings

ELUT Stock Data

29.79M
27.80M
2.2%
70.65%
0.06%
Medical Devices
Biological Products, (no Disgnostic Substances)
Link
United States
SILVER SPRING